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We examined the transduction efficiency of a VSV-G (vesicular stomatitis virus G protein)-pseudotyped vector encoding
b-galactosidase (lacZ) into human solid tumor cell lines and murine fibroblasts, compared with that of an amphotropic vector
carrying the same RNA sequence. The ratio of cells transduced with the VSV-G-pseudotyped vector corresponded closely
to 1 2 e2m.o.i., as predicted from a Poisson distribution of transduction to the entire cellular population, while this was not the
case for the amphotropic vector. Here m.o.i. (multiplicity of infection) is defined as the ratio of input infectious units (titrated
on the corresponding cell line) to the number of cells used for the transduction. At high m.o.i.s (values greater than 3), the
VSV-G-pseudotyped vector transduced approximately 95% of the culture population of all cell lines examined. The trans-
duction efficiency of the amphotropic vector, however, was not dose-dependent and reached a plateau or even decreased,
especially at high m.o.i.; this may be attributable at least in part to the presence of envelope protein and noninfectious
particles that compete for the receptor of infectious amphotropic virus. The copy number of integrated vector proviral DNA
and the expression level of lacZ increased almost linearly with the dose of the VSV-G-pseudotyed vector, which could readily
achieve multiple transduction of more than 10 copies per cell and afforded about 100-fold more transgene product than could
be achieved with the amphotropic vector. These features of both the VSV-G-pseudotyped vector and the amphotropic vector
were essentially unaffected by purification using centrifugation. These properties of the vector should be highly advanta-
geous for gene transfer into entire populations of human tumor cell lines at a designed dosage. © 1999 Academic Press
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Amphotropic retrovirus vectors are powerful tools for
ene transfer into human and murine cells in basic
esearch and human gene therapy. Several reports have
ndicated, however, that amphotropic vectors are not
ble to introduce transgenes into the entire population of
ibroblasts or several other cell lines of mouse or human
rigin in vitro, even when transduction is performed at a
igh titer of infectious vector particles (Morgan et al.,
995; Naviaux et al., 1996). The reasons for this phenom-
non are not yet fully understood, but possible explana-
ions include inhibitory factors present in the ampho-
ropic virus stock (Doux et al., 1996; Batra et al., 1997),
eterogeneity in the cell-cycle phase of the host cells
Naviaux et al., 1996), or heterogeneity in the number of
he cell-surface receptors. The mechanisms appear to
e complex and might be dependent upon not only the
ell type to be transduced, but also the cell line used for
ackaging. These features of amphotropic vectors are
ractically disadvantageous, especially when genes are
o be introduced into the entire population of a human
1 To whom correspondence and reprint requests should be ad-
Aressed. Fax: 81-3-5449-5449. E-mail: iba@ims.u-tokyo.ac.jp.
109ell culture for the assay of biological effects without
rior selection of transduced cells.
Retrovirus vectors pseudotypes with VSV-G (vesicular
tomatitis virus G) protein have been constructed and
hown to be highly useful (Burns et al., 1993; Yee et al.,
994; Sharma et al., 1996). The pseudotyped vectors had
broad host range (Burns et al., 1993; Matsubara et al.,
996) and relatively high transducing efficiency, probably
ecause the receptors of VSV-G include ubiquitous an-
onic phospholipids (Schlegel et al., 1983; Mastromarino
t al., 1987). This vector has another advantage over
mphotropic vectors in that the pseudotyped vector par-
icles are resistant to concentration by ultracentrifuga-
ion, making possible the convenient purification of virus
tocks and the preparation of high-titer virus stocks
more than 1.0 3 109 infectious units (IU)/ml).
Several efficient systems for producing this vector
ave been developed (Yang et al., 1995; Chen et al., 1996;
ry et al., 1996) and in our system, a “prepacking cell
ine” (PtG-S2) was generated as the first step for the
stablishment of a stable packaging cell line (Arai et al.,
998). The expression of VSV-G in PtG-S2 was designed
o be stringently regulated by the Cre-lox P system and
he cells can be maintained without any leaky VSV-G
seudotype production at all. However, after the intro-
uction of Cre recombinase by the adenovirus vector
xCANCre (Kanegae et al., 1995, 1996), this cell line was
0042-6822/99 $30.00
Copyright © 1999 by Academic Press
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110 ARAI ET AL.fficiently converted into a packaging cell line producing
high titer (1 3 106 IU/ml) of the VSV-G-pseudotyped
ector. Neither RCR nor adenovirus vector was detected
n the virus stock of 1 3 10 7 IU of this VSV-G-
seudotyped vector.
It is not yet fully understood what kinds of virological
roperties of the VSV-G-pseudotyped virus support is
fficient transduction. Therefore we have extensively ex-
mined here the transduction efficiency of a VSV-G-
seudotyped vector into several human cell lines derived
rom human solid tumors and some murine fibroblast cell
ines, using either unconcentrated or concentrated vec-
or stocks. Since it has been shown that amphotropic
irus can be concentrated by low-speed centrifugation
ith a relatively high yield (Bowles et al., 1996), the
esults obtained with the VSV-G-pseudotyped vector
ere compared with those obtained using unconcen-
rated or concentrated amphotropic vectors produced by
packaging cell line that originated from the same
arental cell line as was used for the VSV-G-
seudotyped vector production.
RESULTS
.o.i.-dependent transduction of VSV-G-pseudotyped
ector regardless of purification by concentration
For accurate comparison, we prepared the two retro-
irus vectors from cell lines that were as similar as
ossible; that is, PtG-S21acZ1 for VSV-G-pseudotyped
ector and FLYA41acZ3 for amphotropic vector, both of
hich were derived from the same MoMLV gag-pol-
roducing human fibrosarcoma cell line, FLY (Cosset et
l., 1995). PtG-S21acZ1 contains the VSV-G gene induc-
ble by Cre recombinase, while FLYA41acZ3 constitu-
ively produces amphotropic Env. Both of these vector-
roducing cell lines harbor the same MLV-based vector
NA (MFGnlslacZ) encoding b-galactosidase with a nu-
lear localization signal (Dranoff et al., 1993).
The relationship between transduction efficiency and
he virus dose was scrutinized in two murine fibroblasts
ines (NIH3T3, 3Y1) and one cell line (MIA PaCa-2) de-
ived from human pancreatic carcinoma (Fig. 1). For the
uantitation of virus dosage, we used m.o.i. (multiplicity
f infection), which is defined here as follows: the ratio of
nput infectious virus particles (titrated on the corre-
ponding cell line as the indicator) to the number of cells
n the culture used for the transduction. The transduction
fficiency of the concentrated VSV-G-pseudotyped vector
howed similar dose-dependency in all three cell lines,
nd it was very close to that expected for a Poisson
istribution of transduction onto the entire cell popula-
ion (1 2 e2m.o.i.). This equation assumes that virus parti-
les are distributed randomly into individual cells (Luria
t al., 1978). We also tested the dose-dependency using
nconcentrated VSV-G virus stock directly collected fromhe culture fluid of the packaging cell line (1.0 3 106 IU/ml tFIG. 1. Transduction efficiency of the VSV-G-pseudotyped vector
nd the amphotropic vector in three cell lines. LacZ with a nuclear
ocalization signal was introduced into 3Y1 (A), NIH3T3 (B), or MIA
aCa-2 (C) by the use of concentrated VSV-G-pseudotyped vector
open circles), unconcentrated VSV-G-pseudotyped vector (closed
ircles), concentrated amphotropic vector (open squares), or un-
oncentrated amphotropic vector (closed squares) at the indi-
ated m.o.i.s. Three days after the transduction, cells were fixed
nd LacZ-stained, and the percentage of cells with blue nuclei
as determined by counting more than 300 cells. Error bars repre-
ent standard deviation. The theoretical curves of transfection ex-
ected for Poisson distribution (1 2 e2m.o.i.) are plotted by openriangles.
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111TRANSDUCTION OF VSV-G-PSUEDOTYPED VECTORs titrated on 3Y1 cells). The results clearly indicated that
he transduction efficiency was unaffected by vector pu-
ification by ultrancentrifugation (Fig. 1), and the dose-
ependent transduction observed here was shown to be
n intrinsic feature of the VSV-G-pseudotyped vector
ather than a result of purification.
As for the amphotropic vector, it was able to transduce
he gene as efficiently as the VSV-G-pseudotyped vector
t m.o.i.s of less than 0.3, but in all three cell lines
xamined, its efficiency deviated from that expected for a
oisson distribution, reaching a plateau at an m.o.i. of
round 1–3. Such a dose-dependency of an amphotropic
irus encoding LacZ was also reported previously in
IH3T3 cells, and the maximum percentage of trans-
uced cells was only 34.5% (Morgan et al., 1995), in good
ccordance with our observation. When very high m.o.i.s
uch as 30 were used (nearly undiluted virus stocks
ere used in these transductions), transduction effi-
iency was rather reduced. The results might suggest
hat the virus stocks contained some transduction-inhib-
tory factors that lose their inhibitory function upon dilu-
ion. This idea was supported by the following experi-
ents; when the supernatant of the ultracentrifuged virus
tock of the amphotropic vector was used as a diluent for
he titration of the amphotropic vector, the titer was
ecreased to 11% of that obtained using fresh DMEM as
he diluent (Table 1). We further tested the inhibitory
ffects in conditioned media prepared from the parental
ell lines FLY and FLYA13, neither of which harbors
ector DNA. The conditioned medium from FLYA13, as
ell as its supernatant after centrifugation, contained
nhibitory factors for amphotropic vector, while that from
LY did not. These results suggested the amphotropic
nvelope protein at least partly contributes to the inhibi-
ion of the transduction by the amphotropic vector. This
dea is consistent with our observation that none of the
onditioned media influenced transduction by the VSV-
T
Effect of Diluents on Titer of VSV-G-P
MEM 10% FCS
upernatant of ultracentrifuged amphotropic vectora
onditioned medium from FLYb
onditioned medium from FLYA13c
upernatant of centrifuged conditioned medium from FLYA13
eat-inactivated amphotropic vectore
a The supernatant still contained a small amount of amphotropic ve
b FLY cells: MoMLV gag-pol-producing cell line.
c FLYA13 cells: a derivative of FLY, MoMLV gag-pol, and amphotropi
d NT, not tested.
e Amphotropic vector was treated at 56°C for 30 min.-pseudotyped vector, which uses completely different peceptors, including acidic phospholipids. It was re-
orted that proteoglycans secreted from packaging cell
ines were able to inhibit the transduction by ampho-
ropic vector (Doux et al., 1996). However, it seemed
nlikely that proteoglycans played a major role here,
ecause the VSV-G-pseudotyped vector, which is also
ensitive to proteoglycans (Batra et al., 1997), was not
ffected by the same conditioned media and because
he inhibitory factor detected here was inactivated (Table
) by heating at 56°C for 30 min, under which conditions
roteoglycans are stable (Doux et al., 1996).
Since it was recently reported that amphotropic vector
an be purified efficiently by low-speed centrifugation,
e examined whether this protocol could remove the
nhibitory factors. As shown in Fig. 1, however, concen-
ration by centrifugation did not elevate but rather re-
uced the transduction efficiency. This result suggests
hat the pellets of the virus stock after low-speed centrif-
gation also contain inhibitory factors such as noninfec-
ious particles and that the centrifugation process is
nevitably accompanied by the conversion of some infec-
ious particles into nonfunctional particles and/or the
elease of soluble inhibitory factors such as Env protein.
oth the copy number of proviral DNA and the level
f LacZ expression increased linearly with dosage
f VSV-G-pseudotyped vector
Since the analysis of transduction efficiency sug-
ested multiple transduction by the VSV-G-pseudotyped
ector at high m.o.i.s, we next examined the average
opy number of the proviral DNA in the transduced 3Y1
ulture using Southern blot analysis (Fig. 2).
In 3Y1 cells transduced with the pseudotyped vector at
arious m.o.i.s, single bands of the expected size were
etected in the digests with BamHI, which cuts out the
ull-length lacZ sequences. The average copy number
yped Vector and Amphotropic Vector
-G-pseudotyped vector Amphotropic vector
IU/ml) Control (%) Titer (IU/ml) Control (%)
105 100 5.0 3 106 100
105 83 6 4.3 5.3 3 105 11 6 2.1
105 98 6 2.8 4.0 3 106 80 6 5.0
105 97 6 5.8 2.2 3 105 4.4 6 0.2
d 3.7 3 105 7.4 6 1.3
105 103 6 5.0 4.6 3 106 92 6 8.3
3 104 IU/ml), which was subtracted from the detected titer.
roducing cell line.ABLE 1
seudot
VSV
Titer (
9.2 3
7.6 3
9.0 3
8.9 3
NT
9.5 3
ctor (3.5
c env-per 3Y1 (rat) cell was quantitated with an image analyzer
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112 ARAI ET AL.Fuji BAS2000) by using as a control a human cell line,
tG-S2lacZ1, which harbors four copies of MFGnlslacZ
er cell as judged from the result of digestion with NcoI,
aving a single cutting site in the vector DNA (Fig. 2). The
alculated copy numbers per cell were 1.3, 2.8, 7.0, and
5 in 3Y1 transduced with the pseudotyped vector at
.o.i.s of 1, 3, 10, and 30, respectively. The copy number
ncreased almost linearly with viral dosage, through it
as slightly retarded at high m.o.i. A similar linear in-
rease in the copy number was also observed when
IH3T3 was transduced with the VSV-G-pseudotyped
ector (data not shown).
When a 3Y1 was transduced with the pseudotyped
ector at an m.o.i. of 100, a significant proportion of the
ell population became detached from the plate within 2
ays. Since apoptotic cells were detected among these
ells at 1 day after transduction by means of the TUNEL
ethod (data not shown), proviral integration with a very
igh copy number seems to cause cell death. While we
id not address the reasons for this induction of apopto-
is, a major factor could be that the multiple integration
auses insertional mutations in essential genes. The
oxicity of the overproduced LacZ was not the major
eason, because LacZ activity observed in 3Y1 trans-
uced at m.o.i. 100 at 1 day after the transduction was
ess than that detected in 3Y1 transduced at m.o.i. 30 at
days after the transduction, and the latter cells showed
nly marginal signs of apoptosis (data not shown).
To determine the expression levels of LacZ in cells
ransduced with VSV-G-pseudotyped vector or ampho-
ropic vector, LacZ activity per cellular protein was de-
ermined 3 days after the transduction. In 3Y1, NIH3T3,
nd MIA PaCa-2 transduced with the VSV-G-pseudo-
yped vector, LacZ expression levels increased linearly
FIG. 2. Southern blotting analysis of 3Y1 cells transduced with the
SV-G-pseudotyped vector. 3Y1 cells transduced at m.o.i.s of 1, 3, 10,
nd 30 were grown for 10 days after the transduction. High-molecular-
eight chromosomal DNA was isolated from the cells and completely
igested with BamHI. The digested DNA samples (1 or 10 mg) were
eparated on 1.0% agarose gel and 3.1-kb bands (arrows on the left)
ere detected. Arrowheads on the left are the molecular weight mark-
rs (Lambda HindIII digests). As a control, chromosomal DNA of
tG-S2 lacZ1 was also prepared, digested with either BamHI (B) or
coI (N), and separated on the same gel (2.5 or 10 mg). NcoI digests
ave four bands (arrows on the right), indicating the presence of four
opies of provirus/diploid PtG-S2lacZ1.ith respect to the m.o.i. at which the transduction was oerformed (Fig. 3). Again, this result was not affected by
hether or not the vector had been purified by ultracen-
rifugation. This is consistent with the finding that the
SV-G-pseudotyped vector can achieve multiple trans-
FIG. 3. LacZ activities in three cell lines transduced with either VSV-G-
seudotyped vector or amphotropic vector. 3Y1 (A), NIH3T3 (B), or MIA
aCa-2 (C) was transduced with concentrated VSV-G-pseudotyped vector
open circles), unconcentrated VSV-G-pseudotyped vector (closed circles),
r unconcentrated amphotropic vector (closed squares) at the indicated
.o.i.s. LacZ activities were determined 3 days after the transduction using-nitrophenyl-b-D-galactopyranoside.
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113TRANSDUCTION OF VSV-G-PSUEDOTYPED VECTORuction in a precisely m.o.i.-dependent manner. In the
ase of the amphotropic vector, however, the increase of
acZ activity per cell was retarded above an m.o.i. of 1–3
nd the activity was even reduced at an m.o.i. of 30 in all
hree cell lines (Fig. 3), in agreement with the transduc-
ion efficiency data in Fig. 1. As a result, cells transduced
ith the VSV-G-pseudotyped vector were able to induce
n approximately 100-fold higher level of the transgene
roduct than that in cells transduced with the ampho-
ropic vector.
ransduction of VSV-G-pseudotyped vector was
fficient in all human solid tumor cell lines examined
We examined whether the efficient transduction by
SV-G-pseudotyped vector also occurred in other human
olid tumor cell lines. Each cell line was transduced with
he virus same stocks shown in Fig. 1 and the titers were
etermined with each cell line listed in Table 2 as the
ndicator. The results show that each cell line has a
istinct susceptibility to each of the vectors. The titers of
he stock of VSV-G-pseudotyped vector ranged from
.9 3 109 IU/ml (A549) to 1.1 3 107 IU/ml (HCT-15), while
n the case of the amphotropic vector, the titers also
anged over two orders of magnitude (from 8.7 3 106
U/ml (HCT116) to 3.3 3 104 IU/ml (HCT-15)). When all the
ell lines listed in Table 2 were transduced at high m.o.i.s
values greater than 3), all the cell lines were efficiently
ransduced with the VSV-G-pseudotyped vector (around
5% of the entire populations). On the other hand, trans-
uction efficiency of the amphotropic vector was less
han 50%, except for PtG-S2 (Table 1); furthermore, the
ransduction efficiency did not improve, but rather de-
reased, in transduction at higher m.o.i., as was found in
T
Transduction by VSV-G-Pseudo
Cell line Origin
VS
Titer (IU/m
IH3T3 Mouse fibroblast 1.1 3 10
Y1 Rat fibroblast 1.1 3 10
tG-S2 Human fibrosarcoma 9.2 3 10
OLO 320DM Human colon adenocarcinoma 6.3 3 10
LD-1 Human colon adenocarcinoma 2.3 3 10
CT-15 Human colon adenocarcinoma 1.1 3 10
T-29 Human colon adenocarcinoma 1.1 3 10
CT116 Human colon carcinoma 9.3 3 10
CI-H460 Human lung large cell carcinoma 9.7 3 10
549 Human lung carcinoma 1.9 3 10
DA-MB-435S Human breast ductal carcinoma 3.9 3 10
SN1 Human pancreatic adenocarcinoma 1.2 3 10
IA PaCa-2 Human pancreatic carcinoma 1.0 3 10
a m.o.i. (input infectious units/cell ratio) was determined by titrationhe above three cell lines (Fig. 1). Therefore the unique aeatures of VSV-G-pseudotyped vector seem to be appli-
able to many, if not all, human solid tumor lines.
DISCUSSION
We have demonstrated here that VSV-G-pseudotyped
ector transduces essentially the entire population of
ach cell line in an almost dose-dependent manner re-
ardless of purification by concentration. Since the trans-
uction efficiency with the VSV-G-pseudotyped vector
as very close to that predicted from a Poisson distri-
ution of gene transfer to the entire cellular population,
ll the cells appeared to have similar susceptibility to this
ector. Even at high m.o.i.s of around 30, the transduction
fficiency was almost linearly related to the virus dos-
ge, with only slight retardation. This feature enabled us
o achieve abut 100-fold higher transgene expression
evels of a control exogenous gene, lacZ, than those
chieved with the amphotropic vector.
In contrast, gene transfer into the majority of the
ellular population was difficult in the case of the
mphotropic vector carrying the same RNA sequence.
ur results suggested that the saturation of transduc-
ion efficiency by the amphotropic vector was caused
artly by inhibitory factors such as Env protein that
annot be precipitated by ultracentrifugation and
artly by noninfectious particles. These factors would
ompete with and inhibit the binding of infectious
articles to the receptor of the amphotropic virus, a
hosphate transporter (Kavanaugh et al., 1994). We do
ot think that our VSV-G-pseudotyped virus has
maller amounts of noninfectious particles or free en-
elope protein (VSV-G) in the virus stock compared
ith those in the amphotropic virus, based on protein
Vector or Amphotropic Vector
eudotyped vector Amphotropic vector
Transduction % (m.o.i.)a Titer (IU/ml) Transduction % (m.o.i.a)
94.7 (10) 7.7 3 106 42.7 (3.0)
96.8 (3.0) 6.7 3 106 48.6 (3.0)
94.3 (10) 7.4 3 106 91.5 (18)
97.7 (6.0) 1.4 3 105 10.5 (0.16)
97.1 (6.7) 2.4 3 105 36.7 (2.7)
92.7 (2.0) 3.3 3 104 14.6 (0.2)
94.4 (11) 1.0 3 106 27.3 (3.3)
95.2 (10) 8.7 3 106 34.1 (19)
94.1 (47) 9.3 3 105 9.8 (3.3)
98.8 (22) 1.6 3 106 4.8 (2.5)
94.1 (9.0) 1.7 3 106 30.5 (3.5)
99.1 (22) 1.4 3 106 18.9 (2.7)
92.9 (16) 5.3 3 106 20.4 (14)
he same cell line as an indicator.ABLE 2
typed
V-G-ps
l)
9
9
8
7
7
7
9
8
7
9
8
8
9nalysis of virus stocks giving the same titer (data not
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114 ARAI ET AL.hown). Rather, we propose that the receptors for
SV-G, which are known to include ubiquitous and
bundant anionic phospholipids (Schlegel et al., 1983;
astromarino et al., 1987), would not easily be satu-
ated by the contaminating noninfectious particles or
ree VSV-G proteins in our virus stocks. This is con-
istent with our previous finding that cells that express
uite high levels of VSV-G are fully susceptible to
SV-G-pseudotyped vector (Arai et al., 1998), estab-
ishing no interference, unlike the case of natural ret-
oviruses.
These virological features of the VSV-G-pseudotyped
ector are highly advantageous both for basic research
sing human tumor cell lines and in human gene therapy.
or example, this vector should be a powerful tool for
nalysis of the biological functions of exogenous genes
t several dosages, making use of the dose-dependent
ransduction. VSV-G-pseudotyped vector would also be
dvantageous for transgene production at high levels
about 100-fold greater than would be obtainable with
mphotropic vector). Furthermore, biological functions
hat cause G1 arrest, apoptosis, or suppression of tu-
origenicity could be efficiently tested in the entire cell
ulture population by using a VSV-G-pseudotyped vector
ithout the involvement of a selection process after the
ransduction. Such a dissection of human tumor cell
ines would be useful in designing efficient dominant
egative mutants with anti-oncogenic functions and also
n the categorization of human tumor cell lines in terms of
he disordered signal transduction pathways.
MATERIALS AND METHODS
ell lines
COLO320DM, DLD-1, HCT-15, HT-29 (human colon ad-
nocarcinoma cells), HCT116 (human colon carcinoma
ells), NCI-H460 (human lung large cell carcinoma cells),
549 (human lung carcinoma cells), MDA-MB-435S (hu-
an breast duct carcinoma cells), MIA PaCa-2 (human
ancreatic carcinoma cells), and PSN1 (human pancre-
tic adenocarcinoma cells) were purchased from ATCC.
hese cells and 3Y1 (rat fibroblast cells) were cultured in
MEM (high glucose) supplemented with 10% fetal calf
erum (FCS). NIH3T3 (mouse fibroblast cells) was pur-
hased from ATCC and cultured in DMEM (low glucose)
upplemented with 10% calf serum. PtG-S2 (prepackag-
ng cell line for VSV-G-pseudotyped vector) and PtG-
2lacZ1 (PtG-S2 harboring MFGnlslacZ vector) were cul-
ured in DMEM (high glucose) supplemented with 10%
CS, 4 mg/ml blasticidin S, and 1 mg/ml G418 (Gibco).
LY and FLYA13 were cultured in DMEM (high glucose)
upplemented with 10% FCS, 4 mg/ml blasticidin S,
nd/or 10 mg/ml phleomycin as described previouslyCosset et al., 1995; Arai et al., 1998). cetrovirus and its concentration
DMEM (high glucose) supplemented with 10% FCS
ithout selection drugs was used for retrovirus vector
reparation. The VSV-G-pseudotyped vector was har-
ested every 24 h from PtG-S2lac1 at 3–5 days after
ntroduction of Cre recombinase, as described previ-
usly (Arai et al., 1998). The VSV-G-pseudotyped vector
as concentrated by ultracentrifugation at 19,500 rpm for
00 min. The pellet was suspended in DMEM without
CS as described previously (Arai et al., 1998). The re-
overy of infectious particles ranged from 50 to 80%.
mphotropic retrovirus vector was collected from
LYA4lacZ3 (Cosset et al., 1995) every 24 h. The ampho-
ropic vector was concentrated at 6000 g for 16 h, and the
ellet was suspended in DMEM without FCS. Recovery
f the infectious particles was 50 to 90%.
etrovirus transduction and determination
f its efficiency
All transduction was carried out in the presence of 8
g/ml Polybrene (Sigma) 1 day after passage. Three
ays after transduction, cells were fixed with 1.25% glu-
araldehyde. Transduction of lacZ was visualized by us-
ng X-Gal (5-bromo-4-chloro-3-indolyl-b-D-galactopyrano-
ide) (Wako) as described previously (Arai et al., 1998).
he titer of each cell line was determined by counting the
umbers of clones with blue nuclei in cultures trans-
uced with the vector in 10-fold serial dilutions made by
dding fresh culture medium. In order to examine the
nhibitory factors, vectors were diluted with conditioned
edium or attenuated amphotropic vectors and titrated.
or precise determination of transduction efficiency,
ransduction was carried out as follows. Cells were
eeded in a 96-well plate 1 day before transduction and
he cell number was determined just before the trans-
uction to allow accurate evaluation of the m.o.i. Trans-
uction efficiency was determined by counting more
han 300 cells with or without blue-stained nuclei. All
xperiments were carried out in triplicate unless other-
ise noted.
outhern blotting
Copy numbers of integrated vector DNA were deter-
ined as follows. Total chromosomal DNA was prepared
y standard techniques (Sambrook et al., 1989) from
ransduced cells. The digested chromosomal DNA was
ransferred to a nylon membrane (Hybond-N1; Amer-
ham) and probed with a 3.1-kb BamHI fragment isolated
rom pMFGnlslacZ (carrying the LacZ gene) labeled with
32P. The density of hybridized bands was determined with
BAS2000 image analyzer (Fuji). Chromosomal DNA
rom PtG-S2lacZ1, which harbors vector DNA at four
opies per cell, was used as the control for copy number
alculation.
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The LacZ activity in transduced cells was determined
y using a b-galactosidase enzyme assay system (Pro-
ema) with o-nitrophenyl-b-D-galactopyranoside. Total
ell lysates were adjusted with lysates that did not con-
ain LacZ to avoid the effect of endogenous activity.
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